Neurocrine Biosciences (NBIX) Non Operating Interest Expenses (2017 - 2026)
Neurocrine Biosciences (NBIX) posted Non Operating Interest Expenses of $2.9 million for Q2 2026.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Non Operating Interest Expenses (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Neurocrine Biosciences was $5.1 million, up 54.5% year-over-year; for FY2023, it came in at $4.6 million, down 35.2% from FY2022.
- Annual Non Operating Interest Expenses has declined for three consecutive years, with a five-year compound annual growth rate of -31.5% (FY2018 to FY2023).
- In prior years, Neurocrine Biosciences' Non Operating Interest Expenses was $7.1 million in FY2022 (-72.5%), $25.8 million in FY2021 (-21.3%), $32.8 million in FY2020 (+2.5%) and $32 million in FY2019 (+4.9%).
- The Q2 2026 figure stands as the highest quarterly Non Operating Interest Expenses since Q4 2021.
- The year-over-year decline in Non Operating Interest Expenses has ranged between 0.0% (Q1 2024) and 83.3% (Q4 2022) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 2.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.90 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 6.60 Mn |
| Sep 30, 2021 | 6.60 Mn |
| Jun 30, 2021 | 6.20 Mn |
| Mar 31, 2021 | 6.40 Mn |
| Dec 31, 2020 | 7.80 Mn |
| Sep 30, 2020 | 8.50 Mn |
| Jun 30, 2020 | 8.30 Mn |
| Mar 31, 2020 | 8.20 Mn |
| Dec 31, 2019 | 8.20 Mn |
| Sep 30, 2019 | 8.00 Mn |
API Access
Neurocrine Biosciences Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();